RIGI and viral infectious disease: Our results here show that as a PRR that functions in innate immunity against virus infections, RIG-I is also highly expressed on HNSCC cells and its activation contributes to tumor growth and progression in response to a low dose of 3p-RNA, whereas leading to apoptosis in response to a high dose of 3p-RNA.